2-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl octadeca-6,9,12,15-tetraenoate



Compound IDCDAMM00205
Common name2-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl octadeca-6,9,12,15-tetraenoate
IUPAC name[2-hydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] octadeca-6,9,12,15-tetraenoate
Molecular formulaC27H44O9

Experimental data

Retention time31.64
Adduct[M+H]+
Actual mz513.305
Theoretical mz513.306
Error0.77
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.5077

Identifiers and class information

Inchi keyOBLUCMMNMFITHB-QLTJWRQVNA-N
SmilesCCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COC1C(C(C(C(O1)CO)O)O)O)O
SuperclassLipids and lipid-like molecules
ClassGlycerolipids

Pharmacokinetic properties

Number of descriptor values(#stars)5
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)23
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)512.639
Computed dipole moment(dipole)5.424
Total solvent accessible surface area (SASA)956.805
Hydrophobic component of SASA (FOSA)644.437
Hydrophilic component of SASA (FISA)255.254
Pie component of the SASA (PISA)57.115
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1779.71
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)13.9
Free energy of solvation of dipole (dip^2/V)0.0165298
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0324845
Globularity descriptor (glob)0.742291
Predicted polarizability in cubic angstroms (QPpolrz)50.847
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.533
Predicted octanol/gas partition coefficient (QPlogPoct)31.47
Predicted water/gas partition coefficient (QPlogPw)20.087
Predicted octanol/water partition coefficient (QPlogPo/w)2.378
Predicted aqueous solubility (QPlogS)-4.565
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.006
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.974
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)37.612
Predicted brain/blood partition coefficient (QPlogBB)-3.911
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)14.271
Predicted skin permeability, log Kp (QPlogKp)-3.814
PM3 calculated ionization potential (IP(ev))9.695
PM3 calculated electron affinity (EA(eV))-0.716
Number of likely metabolic reactions (#metab)11
Prediction of binding to human serum albumin (QPlogKhsa)-0.425
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)56.108
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)159.275
Number of nitrogen and oxygen atoms (#NandO)9
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P10253GAALysosomal alpha-glucosidase (by homology)T31514SEA
O00519FAAHAnandamide amidohydrolaseT11754SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
Q8TDS5OXER1Oxoeicosanoid receptor 1T68834SEA
P16109SELPP-selectinT10965SEA
P14151SELLLeukocyte adhesion molecule-1T60526SEA
P60568IL2Interleukin-2T61698SEA
P17931LGALS3Galectin-3T72038SEA
Q9HBW0LPAR2Lysophosphatidic acid receptor Edg-4T39380SEA
P43657LPAR6Lysophosphatidic acid receptor 6T13484SEA
Q9H1C0LPAR5Lysophosphatidic acid receptor 5T18616SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
Q9UPC5GPR34Probable G-protein coupled receptor 34T73859SEA
O00398P2RY10Putative P2Y purinoceptor 10T00488SEA
Q9BXC1GPR174Probable G-protein coupled receptor 174T87661SEA
Q9UBY5LPAR3Lysophosphatidic acid receptor Edg-7T95923SEA
Q92633LPAR1Lysophosphatidic acid receptor Edg-2T92640SEA
Q99677LPAR4Lysophosphatidic acid receptor 4T58130SEA
O60603TLR2Toll-like receptor 2T82078SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T31514DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]P10253GAA
T11754DI0101Corneal disease[ICD-11: 9A76-9A78]O00519FAAH
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T10965DI0088Circulatory system disease[ICD-11: BE2Z]P16109SELP
T10965DI0381Sickle-cell disorder[ICD-11: 3A51]P16109SELP
T60526DI0037Asthma[ICD-11: CA23]P14151SELL
T60526DI0088Circulatory system disease[ICD-11: BE2Z]P14151SELL
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3
T95923DI0146Fibrosis[ICD-11: GA14-GC01]Q9UBY5LPAR3
T95923DI0399Systemic sclerosis[ICD-11: 4A42]Q9UBY5LPAR3
T92640DI0146Fibrosis[ICD-11: GA14-GC01]Q92633LPAR1
T92640DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q92633LPAR1
T92640DI0351Psoriasis[ICD-11: EA90]Q92633LPAR1
T92640DI0399Systemic sclerosis[ICD-11: 4A42]Q92633LPAR1
T82078DI0346Prostate cancer[ICD-11: 2C82]O60603TLR2

Copyright © 2025